logo

Ligand Pharmaceuticals Inc (LGND)



Trade LGND now with
  Date
  Headline
6/15/2020 8:39:05 AM Ligand Says Vernalis Research Expands Oncology Research Collaboration With Servier
5/29/2020 8:06:45 AM Ligand Reports Icagen's Expansion Of Collaboration With Roche To Develop Therapies For Neurological Diseases
5/6/2020 7:12:58 PM Ligand Pharmaceuticals Inc (LGND) Has Raised Its 2020 EPS Estimate To 3.65 From 3.62
5/6/2020 7:12:17 PM Ligand Pharmaceuticals Inc (LGND) Has Raised Its 2020 Revenue Estimate To $140 Mln From $133 Mln
5/6/2020 5:21:32 PM Ligand Pharma Q1 Loss/share $1.46 Vs. Profit $31.32 Year Ago
2/27/2020 8:03:49 AM Ligand Now Expects 2020 Total Revenues To Be About $133 Mln And EPS To Be $3.62
2/11/2020 4:17:50 PM Ligand To Acquire The Core Assets Of Icagen, Inc.'s North Carolina Operations
2/6/2020 4:04:46 PM Ligand Q4 Loss/share $0.43 Vs. Loss $2.02 Year Ago
12/2/2019 8:33:41 AM Ligand Enters Worldwide OmniAb License Agreement With Sanofi
11/8/2019 8:34:50 AM Ligand Pharma Unveils Positive Results From Phase 1 Trial of Captisol-enabled Iohexol Program At ASN Kidney Week 2019
11/5/2019 4:09:34 PM Ligand Pharmaceuticals Inc (LGND) Has Lowered Its 2019 EPS Estimate To 3.00 From 3.20
11/5/2019 4:05:24 PM Ligand Pharmaceuticals Q3 Loss Per Share $0.81 Vs EPS $2.80 Prior Year